Page 38 - The Smart Investor News

Go Digit shares climb 10% as institutional investors pick up stake

According to NSE, Aditya Birla Sunlife Mutual Fund has purchased 2.1 million shares of Digit General Insurance, while JPMorgan (Taiwan) Eastern Technology Fund also acquired 1.1 million shares.

Wipro shares tank 7% amid heavy volumes on buyback record date

According to data compiled by Bloomberg, 1.74 million shares were traded in multiple blocks on buyback record date

Juniper Hotels gains 7% on acquisition update; what should investors do?

The northward movement in the company's share price came after it informed the exchanges that it had executed a share purchase agreement (SPA) with Juniper Hospitality Assets Private Limited (JHAPL)

Rajesh Exports shockwave hits LIC stock post Sebi crackdown; analyst weighs

LIC stake in Rajesh Exports: LIC shares traded under pressure today following developments related to Rajesh Exports, in which the insurer holds a 10.8 per cent stake.

Meesho slips 4%; Choice flags lock-in expiry as near-term overhang

Choice Institutional Equities has maintained an 'Add' on Meesho with a target price of ₹210, based on 4x FY28 EV/Revenue, flagging the impending lock-in expiry on June 9, 2026, as a near-term overhang

PhysicsWallah surges 18% as company drops ₹120 crore NBFC plan

The buying on the counter came after the company reversed its earlier decision to build an in-house lending business through its subsidiary FinZ Finance Private Limited

Jain Irrigation zooms 13% on commissioning biochar reactor in Jalgaon

Jain Irrigation Systems Limited (JISL) has commissioned an approximately 20,000 tonne per annum industrial-scale biochar facility in Jalgaon, Maharashtra

R R Kabel up 47% YTD, 21% in a month; Motilal stays Neutral at ₹2,020

Motilal Oswal Financial Services has maintained a 'Neutral' rating on R R Kabel with a target price of ₹2,020 per share

Suzlon advances 2% as JM Financial backs FY31 growth plans, sees 17% upside

The brokerage said Suzlon is recalibrating its strategy from product sales to project sales and, eventually, to becoming a solutions provider

Ideaforge zooms 144% since April, hits 2-year high; what's driving stock?

Ideaforge's revenue is likely to grow at a steady rate over the medium term, in line with geographical diversification, healthy demand, strong order book, and product addition, believes Crisil Ratings

Tenneco Clean Air up 4%; JM Fin sees 19% upside, bets on strong order book

JM Financial has reiterated its 'Buy' rating on Tenneco Clean Air India, saying a strong order book gives earnings visibility. The brokerage maintained its target price of ₹680 per share.

BlueStone gains 6% as JM Financial reiterates 'Buy', sees over 20% upside

At the current market price, JM Financial sees an upside potential of over 20 per cent and has maintained a target price of ₹650 per share

Ashok Leyland skids 5%, hits 6-month low; why CV stock under pressure?

In the past four trading days, the stock price of Ashok Leyland slipped 13% after the company reported muted sales volumes with a decline of 4% YoY at 14,923 units in the month of May 2026.

MOFSL on Shriram Finance: MUFG deal to aid growth; keeps Buy for 28% upside

Following the deal with MUFG, Motilal Oswal said that Shriram Finance is well-positioned to capitalise on emerging growth opportunities, supported by strong execution and deep customer relationships.

Nifty IT snaps 3-day rally, tumbles 6%; TCS, LTM tank up to 9%; here's why

IT stocks witnessed heavy selling pressure on Wednesday tracking overnight losses in technology shares in the US market. Indian ADRs cracked up to 8%.

Choice reiterates 'Buy' on Jeena Sikho, sees 44% upside; stock rises 20%

Analysts Deepika Murarka and Stuti Bagadia expect JSLL to deliver revenue, Ebitda and PAT CAGR of 33.6 per cent, 34.9 per cent and 41.6 per cent, respectively, over FY26-FY29E

ITC slips 9% in 3 days; plunges 32% so far in 2026; should you buy or sell?

Volatility in cigarette volumes and EBIT to moderate from the initial transitionary phase; and given the MRP revisions are still underway, the outlook for cigarette biz remains uncertain, analysts.

IndusInd Bank falls 3% on insider trading, governance lapses allegations

The complaint adds to mounting scrutiny of IndusInd Bank ​after ​its March 2025 disclosure of a ₹2,000 crore derivatives accounting ​discrepancy.

Concord Biotech jumps 8% after USFDA approves Mycophenolate Mofetil ANDA

Concord Biotech received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.

NHPC shares rise 5% as govt exercises greenshoe in OFS; retail window opens

The buying on the counter came after the Government of India, acting through the Ministry of Power, exercised the oversubscription option in the ongoing offer for sale (OFS)